| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $10.68B | $10.13B | $9.83B |
| YoY Revenue Growth % | +5.4% | +3.0% | — |
| Gross Profit | $3.94B | $3.80B | — |
| Gross Margin % | 36.9% | 37.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.74B | $1.71B | $1.45B |
| Operating Margin % | 16.3% | 16.9% | 14.7% |
| Net Income (GAAP) | $382.0M | $1.45B | -$6.66B |
| EBITDA (Normalized) | $1.86B | $1.79B | $1.80B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | — | $4.33B |
| Capital Expenditures (CapEx) | $154.0M | $97.0M | $442.4M |
| Free Cash Flow (FCF) | — | — | $3.89B |
| FCF Margin % | — | — | 39.6% |
| Return on Invested Capital (ROIC %) | 6.1% | 5.5% | 16.0% |
| Cash & Short-Term Equivalents | $599.0M | $834.0M | — |
| Total Debt (Short + Long Term) | $9.07B | $9.69B | $2.76B |
| Total Stockholders' Equity | $13.90B | $15.70B | $5.66B |